Drug Profile
Research programme: NMDA antagonists - Wyeth
Alternative Names: EAA 129; WAY 209129Latest Information Update: 03 Oct 2011
Price :
$50
*
At a glance
- Originator Wyeth
- Class 2 ring heterocyclic compounds; Benzoates; Phosphoric acid esters
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 07 Aug 2009 No development reported - Preclinical for Pain in United Kingdom (PO)
- 30 May 2006 Preclinical development for Pain in the USA (PO)